Suppr超能文献

探索干细胞技术在治疗感音神经性听力损失中的应用。

Exploring the application of stem cell technology in treating sensorineural hearing loss.

作者信息

Li Min, Ma Rongyue, Li Qing, Guo Min

机构信息

Otorhinolaryngology Department, First Affiliated Hospital of Kunming Medical University Kunming, Yunnan, China.

Nephrology Department, First Affiliated Hospital of Kunming Medical University Kunming, Yunnan, China.

出版信息

Am J Stem Cells. 2024 Aug 25;13(4):212-221. doi: 10.62347/AEIV5813. eCollection 2024.

Abstract

Sensorineural deafness mainly occurs due to damage to hair cells, and advances in stem cell technology, especially the application of induced pluripotent stem cells (iPSCs) and adult stem cells, provides new possibilities for hair cell regeneration. This review describes the basic knowledge of stem cells and their important applications in regenerative medicine, as well as recent progress in stem cell research in the field of hair cell regeneration, especially the induced differentiation of hair-like cells. At the same time, we also point out the challenges facing current research, including differentiation efficiency, cell stability issues, and treatment safety and long-term efficacy considerations. Finally, we look forward to the direction of future research, and emphasize the importance of the cell differentiation mechanism, simulation of the inner ear microenvironment, safety assessment, and personalized treatment strategies. In conclusion, despite many challenges, stem cell technology has shown great potential in the field of hearing research and is expected to bring revolutionary treatment options for patients with sensorineural hearing loss in the future.

摘要

感音神经性耳聋主要是由于毛细胞受损引起的,而干细胞技术的进步,特别是诱导多能干细胞(iPSC)和成体干细胞的应用,为毛细胞再生提供了新的可能性。本综述介绍了干细胞的基础知识及其在再生医学中的重要应用,以及毛细胞再生领域干细胞研究的最新进展,特别是类毛细胞的诱导分化。同时,我们也指出了当前研究面临的挑战,包括分化效率、细胞稳定性问题以及治疗安全性和长期疗效考量。最后,我们展望了未来研究的方向,并强调了细胞分化机制、内耳微环境模拟、安全性评估和个性化治疗策略的重要性。总之,尽管面临诸多挑战,干细胞技术在听力研究领域已展现出巨大潜力,有望在未来为感音神经性听力损失患者带来革命性的治疗选择。

相似文献

1
Exploring the application of stem cell technology in treating sensorineural hearing loss.
Am J Stem Cells. 2024 Aug 25;13(4):212-221. doi: 10.62347/AEIV5813. eCollection 2024.
2
Perspectives for the treatment of sensorineural hearing loss by cellular regeneration of the inner ear.
Acta Otorrinolaringol Esp. 2015 Sep-Oct;66(5):286-95. doi: 10.1016/j.otorri.2014.07.009. Epub 2014 Nov 20.
6
Stem cell therapy for the inner ear: recent advances and future directions.
Trends Amplif. 2012 Mar;16(1):4-18. doi: 10.1177/1084713812440336. Epub 2012 Apr 17.
7
Regeneration of Hair Cells: Making Sense of All the Noise.
Pharmaceuticals (Basel). 2011 Jun 1;4(6):848-879. doi: 10.3390/ph4060848.
9
[Strategies for a regenerative therapy of hearing loss. German version].
HNO. 2018 Mar;66(3):179-187. doi: 10.1007/s00106-017-0466-1.
10
A human induced pluripotent stem cell-based modular platform to challenge sensorineural hearing loss.
Stem Cells. 2021 Jun;39(6):697-706. doi: 10.1002/stem.3346. Epub 2021 Feb 8.

本文引用的文献

1
Experimental drugs for the prevention or treatment of sensorineural hearing loss.
Expert Opin Investig Drugs. 2023 Jul-Dec;32(7):643-654. doi: 10.1080/13543784.2023.2242253.
2
The NLRP3 inflammasome as a target for sensorineural hearing loss.
Clin Immunol. 2023 Apr;249:109287. doi: 10.1016/j.clim.2023.109287. Epub 2023 Mar 11.
3
Hearing Recovery Induced by DNA Demethylation in a Chemically Deafened Adult Mouse Model.
Front Cell Neurosci. 2022 Feb 17;16:792089. doi: 10.3389/fncel.2022.792089. eCollection 2022.
4
Small activating RNA activation of ATOH1 promotes regeneration of human inner ear hair cells.
Bioengineered. 2022 Mar;13(3):6729-6739. doi: 10.1080/21655979.2022.2045835.
5
Global return on investment and cost-effectiveness of WHO's HEAR interventions for hearing loss: a modelling study.
Lancet Glob Health. 2022 Jan;10(1):e52-e62. doi: 10.1016/S2214-109X(21)00447-2.
7
Advancements in Stem Cell Technology and Organoids for the Restoration of Sensorineural Hearing Loss.
J Am Acad Audiol. 2021 Nov;32(10):636-645. doi: 10.1055/s-0041-1728677. Epub 2021 May 25.
8
Development of ebselen for the treatment of sensorineural hearing loss and tinnitus.
Hear Res. 2022 Jan;413:108209. doi: 10.1016/j.heares.2021.108209. Epub 2021 Feb 19.
9
A human induced pluripotent stem cell-based modular platform to challenge sensorineural hearing loss.
Stem Cells. 2021 Jun;39(6):697-706. doi: 10.1002/stem.3346. Epub 2021 Feb 8.
10
Therapeutic Application of Mesenchymal Stem Cells for Cochlear Regeneration.
In Vivo. 2021 Jan-Feb;35(1):13-22. doi: 10.21873/invivo.12227.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验